Hahn insists FDA will stick to guidelines for Covid-19 vaccine decisions
Speaking at the Financial Times’ US Pharma and Biotech Summit on Tuesday, FDA commissioner Stephen Hahn said the agency will stick to the standards and criteria it has laid out to approve or authorize applications for vaccines to prevent coronavirus disease.
In recent weeks, Hahn has made numerous statements asserting that the agency will not approve or authorize a vaccine that does not meet the agency’s “rigorous expectations,” despite repeated claims by President Donald Trump that a vaccine could be greenlighted before the November election.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.